Treatment of POEMS syndrome

Current Treatment Options in Oncology

Volumn 5, Issue 3, 2004, Pages 249-257

  Dispenzieri, Angela ^a   Gertz, Morie A ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; IMMUNOGLOBULIN; LEXIDRONAM SAMARIUM SM 153; LOOP DIURETIC AGENT; MELPHALAN; PHENOBARBITAL; PHENYTOIN; PREDNISONE; STRONTIUM 89;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ACUTE LEUKEMIA; ACUTE PANCREATITIS; ALOPECIA; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANOREXIA; ASCITES; ASEPTIC MENINGITIS; AVASCULAR NECROSIS; BEAM THERAPY; BONE MARROW; BONE MARROW SUPPRESSION; BONE NECROSIS; CATARACT; CLUBBING FINGERS; COST EFFECTIVENESS ANALYSIS; CUSHING SYNDROME; DIARRHEA; DIET; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; ENDOCRINE DISEASE; EYE DISEASE; GASTROINTESTINAL DISEASE; GLAUCOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; HYPERGLYCEMIA; HYPERHIDROSIS; HYPOKALEMIA; IMMUNOPATHOLOGY; INFERTILITY; INSOMNIA; LIFESTYLE; LOW DRUG DOSE; LUNG TOXICITY; METABOLIC DISORDER; MOOD DISORDER; MOUTH ULCER; MYELODYSPLASTIC SYNDROME; NAIL DISEASE; NAUSEA; NAUSEA AND VOMITING; NEUTROPENIA; OCCUPATIONAL THERAPY; OSTEOPOROSIS; OSTEOSCLEROSIS; PAPILLEDEMA; PARANEOPLASTIC SYNDROME; PARAPROTEINEMIA; PATHOGENESIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; PHYSIOTHERAPY; PIGMENT DISORDER; PLASMA CELL DYSCRASIA; PLASMACYTOMA; PLEURA EFFUSION; RETROSPECTIVE STUDY; REVIEW; SECOND CANCER; SKIN CANCER; SKIN DISEASE; SKIN MANIFESTATION; THROMBOCYTOSIS; TISSUE REPAIR; TREATMENT PLANNING; DECISION TREE; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

COMBINED MODALITY THERAPY; DECISION TREES; HUMANS; POEMS SYNDROME;

EID: 4444275353     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-004-0016-4     Document Type: Review

References (46)

1. Bardwick PA, Zvaifler NJ, Gill GN, et al.: Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine 1980, 59: 311-322.
2. Nakanishi T, Sobue I, Toyokura Y, et al.: The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 1984, 34: 712-720.
3. Driedger H, Pruzanski W: Plasma cell neoplasia with peripheral polyneuropathy. A study of five cases and a review of the literature. Medicine 1980, 59: 301-310.
4. Soubrier MJ, Dubost JJ, Sauvezie BJ: POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. Am J Med 1994, 97: 543-553.
5. Dispenzieri A, Kyle RA, Lacy MQ, et al.: POEMS syndrome: definitions and long-term outcome. Blood 2003, 101: 2496-2506.
6. Hashiguchi T, Arimura K, Matsumuro K, et al.: Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve 2000, 23: 1051-1056.
7. Watanabe O, Maruyama I, Arimura K, et al.: Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 1998, 21: 1390-1397.
8. Morley JB, Schwieger AC: The relation between chronic polyneuropathy and osteosclerotic myeloma. J Neurol Neurosurg Psychiatry 1967, 30: 432-442.
9. Davis L, Drachman D: Myeloma neuropathy. Successful treatment of two patients and review of cases. Arch Neurol 1972, 27: 507-511.
10. Iwashita H, Ohnishi A, Asada M, et al.: Polyneuropathy, skin hyperpigmentation, edema, and hypertrichosis in localized osteosclerotic myeloma. Neurology 1977, 27: 675-681.
11. Dispenzieri A, Moreno-Aspitia A, Lacy MQ, et al.: Peripheral blood stem cell transplant (PBSCT) in a large series of patients with POEMS syndrome. Biol Blood Marrow Transplant 2004, 10: 14-15.
12. Hogan WJ, Lacy MQ, Wiseman GA, et al.: Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transplant 2001, 28: 305-309.
13. Rovira M, Carreras E, Blade J, et al.: Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation. Br J Haematol 2001, 115: 373-375.
14. Jaccard A, Royer B, Bordessoule D, et al.: High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood 2002, 99: 3057-3059.
15. Peggs KS, Paneesha S, Kottaridis PD, et al.: Peripheral blood stem cell transplantation for POEMS syndrome. Bone Marrow Transplant 2002, 30: 401-404.
16. Soubrier M, Ruivard M, Dubost JJ, et al.: Successful use of autologous bone marrow transplantation in treating a patient with POEMS syndrome. Bone Marrow Transplant 2002, 30: 61-62.
17. Wiesmann A, Weissert R, Kanz L, Einsele H: Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation. Blood 2002, 100: 2679-2680.
18. Barrier JH, Le Noan H, Mussini JM, Brisseau JM: Stabilisation of a severe case of P.O.E.M.S. syndrome after tamoxifen administration [letter]. J Neurol Neurosurg Psychiatry 1989, 52: 286.
19. Enevoldson TP, Harding AE: Improvement in the POEMS syndrome after administration of tamoxifen [letter]. J Neurol Neurosurg Psychiatry 1992, 55: 71-72.
20. Coto V, Auletta M, Oliviero U, et al.: POEMS syndrome: an Italian case with diagnostic and therapeutic implications. Ann Ital Med Int 1991, 6: 416-419.
21. Arima F, Dohmen K, Yamano Y, et al.: [Five cases of Crow-Fukase syndrome]. Fukuoka Igaku Zasshi 1992, 83: 112-120.
22. Authier FJ, Belec L, Levy Y, et al.: All-trans-retinoic acid in POEMS syndrome. Therapeutic effect associated with decreased circulating levels of proinflammatory cytokines. Arthritis Rheum 1996, 39: 1423-1426.
23. Orefice G, Morra VB, De Michele G, et al.: POEMS syndrome: clinical, pathological, and immunological study of a case. Neurol Res 1994, 16: 477-480.
24. Sano M, Terasaki T, Koyama A, et al.: Glomerular lesions associated with the Crow-Fukase syndrome. Virchows Arch A Pathol Anat Histopathol 1986, 409: 3-9.
25. Henze T, Krieger G: Combined high-dose 7S-IgG and dexamethasone is effective in severe polyneuropathy of the POEMS syndrome [letter]. J Neurol 1995, 242: 482-483.
26. Rotta FT, Bradley WG: Marked improvement of severe polyneuropathy associated with multifocal osteosclerotic myeloma following surgery, radiation, and chemotherapy. Muscle Nerve 1997, 20: 1035-1037.
27. Atsumi T, Kato K, Kurosawa S, et al.: A case of Crow-Fukase syndrome with elevated soluble interleukin-6 receptor in cerebrospinal fluid. Response to double-filtration plasmapheresis and corticosteroids. Acta Haematol 1995, 94: 90-94.
28. Kuwabara S, Hattori T, Shimoe Y, Kamitsukasa I: Long-term melphalan-prednisolone chemotherapy for POEMS syndrome. J Neurol Neurosurg Psychiatry 1997, 63: 385-387.
29. Stewart PM, McIntyre MA, Edwards CR: The endocrinopathy of POEMS syndrome. Scott Med J 1989, 34: 520-522.
30. Reulecke M, Dumas M, Meier C: Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy. Neurology 1988, 38: 614-616.
31. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group. J Clin Oncol 1998, 16: 3832-3842.
32. Satoh K, Miura I, Chubachi A, et al.: Development of secondary leukemia associated with (1;7)(q10;p10) in a patient with Crow-Fukase syndrome. Intern Med 1996, 35: 660-662.
33. Reitan JB, Pape E, Fossa SD, et al.: Osteosclerotic myeloma with polyneuropathy. Acta Med Scand 1980, 208: 137-144.
34. Ku A, Lachmann E, Tunkel R, Nagler W: Severe polyneuropathy: initial manifestation of Castleman's disease associated with POEMS syndrome. Arch Phys Med Rehabil 1995, 76: 692-694.
35. Cabezas-Agricola JM, Lado-Abeal JJ, Otero-Anton E, et al. Hypoparathyroidism in POEMS syndrome [letter]. Lancet 1996, 347: 701-702.
36. Crisci C, Barbieri F, Parente D, et al.: POEMS syndrome: follow-up study of a case. Clin Neurol Neurosurg 1992, 94: 65-68.
37. Takatsuki K, Sanada I: Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109 reported cases. Jpn J Clin Oncol 1983, 13: 543-555.
38. Benito-Leon J, Lopez-Rios F, Rodriguez-Martin FJ, et al. Rapidly deteriorating polyneuropathy associated with osteosclerotic myeloma responsive to intravenous immunoglobulin and radiotherapy. J Neurol Sci 1998, 158: 113-117.
39. Frassica DA, Frassica FJ, Schray MF, et al.: Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys 1989, 16: 43-48.
40. Mendenhall CM, Thar TL, Million RR: Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys 1980, 6: 1497-1501.
41. Sternberg AJ, Davies P, Macmillan C, et al.: Strontium-89: a novel treatment for a case of osteosclerotic myeloma associated with life-threatening neuropathy. Br J Haematol 2002, 118: 821-824.
42. Wong VA, Wade NK: POEMS syndrome: an unusual cause of bilateral optic disk swelling. Am J Ophthalmol 1998, 126: 452-454.
43. Broussolle E, Vighetto A, Bancel B, et al.: P.O.E.M.S. syndrome with complete recovery after treatment of a solitary plasmocytoma. Clin Neurol Neurosurg 1991, 93: 165-170.
44. Furuzono H, Moritoyo T, Yamada H, et al.: [A case of Crow-Fukase syndrome which developed seven years following myelopathy of unknown origin]. Rinsho Shinkeigaku 1993, 33: 56-60.
45. Chang YJ, Huang CC, Chu CC: Intravenous immunoglobulin therapy in POEMS syndrome: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1996, 58: 366-369.
46. Silberstein LE, Duggan D, Berkman EM: Therapeutic trial of plasma exchange in osteosclerotic myeloma associated with the POEMS syndrome. J Clin Apheresis 1985, 2: 253-257.